Report Detail
Global Biologics & Biosimilars Market Insights, Forecast to 2025
- RnM3207062 |
- 16 July, 2020 |
- Global |
- 151 Pages |
- QYResearch |
- Pharma & Healthcare
Biologics & Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologics & Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biologics & Biosimilars market is segmented into
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
Segment by Application, the Biologics & Biosimilars market is segmented into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Regional and Country-level Analysis
The Biologics & Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biologics & Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biologics & Biosimilars Market Share Analysis
Biologics & Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biologics & Biosimilars business, the date to enter into the Biologics & Biosimilars market, Biologics & Biosimilars product introduction, recent developments, etc.
The major vendors covered:
fizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
1 Study Coverage
- 1.1 Biologics & Biosimilars Product Introduction
- 1.2 Market Segments
- 1.3 Key Biologics & Biosimilars Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biologics & Biosimilars Market Size Growth Rate by Type
- 1.4.2 Antibiotic
- 1.4.3 Enzyme
- 1.4.4 Hormone
- 1.4.5 Non-Patented Biological Reagents
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global Biologics & Biosimilars Market Size Growth Rate by Application
- 1.5.2 Tumor
- 1.5.3 Diabetes
- 1.5.4 Cardiovascular
- 1.5.5 Hemophilia
- 1.5.6 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biologics & Biosimilars Market Size, Estimates and Forecasts
- 2.1.1 Global Biologics & Biosimilars Revenue 2015-2026
- 2.1.2 Global Biologics & Biosimilars Sales 2015-2026
- 2.2 Global Biologics & Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Biologics & Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Biologics & Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biologics & Biosimilars Competitor Landscape by Players
- 3.1 Biologics & Biosimilars Sales by Manufacturers
- 3.1.1 Biologics & Biosimilars Sales by Manufacturers (2015-2020)
- 3.1.2 Biologics & Biosimilars Sales Market Share by Manufacturers (2015-2020)
- 3.2 Biologics & Biosimilars Revenue by Manufacturers
- 3.2.1 Biologics & Biosimilars Revenue by Manufacturers (2015-2020)
- 3.2.2 Biologics & Biosimilars Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biologics & Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biologics & Biosimilars Revenue in 2019
- 3.2.5 Global Biologics & Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Biologics & Biosimilars Price by Manufacturers
- 3.4 Biologics & Biosimilars Manufacturing Base Distribution, Product Types
- 3.4.1 Biologics & Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biologics & Biosimilars Product Type
- 3.4.3 Date of International Manufacturers Enter into Biologics & Biosimilars Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Biologics & Biosimilars Market Size by Type (2015-2020)
- 4.1.1 Global Biologics & Biosimilars Sales by Type (2015-2020)
- 4.1.2 Global Biologics & Biosimilars Revenue by Type (2015-2020)
- 4.1.3 Biologics & Biosimilars Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biologics & Biosimilars Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biologics & Biosimilars Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biologics & Biosimilars Revenue Forecast by Type (2021-2026)
- 4.2.3 Biologics & Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biologics & Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Biologics & Biosimilars Market Size by Application (2015-2020)
- 5.1.1 Global Biologics & Biosimilars Sales by Application (2015-2020)
- 5.1.2 Global Biologics & Biosimilars Revenue by Application (2015-2020)
- 5.1.3 Biologics & Biosimilars Price by Application (2015-2020)
- 5.2 Biologics & Biosimilars Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biologics & Biosimilars Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biologics & Biosimilars Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biologics & Biosimilars Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Biologics & Biosimilars by Country
- 6.1.1 North America Biologics & Biosimilars Sales by Country
- 6.1.2 North America Biologics & Biosimilars Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Biologics & Biosimilars Market Facts & Figures by Type
- 6.3 North America Biologics & Biosimilars Market Facts & Figures by Application
7 Europe
- 7.1 Europe Biologics & Biosimilars by Country
- 7.1.1 Europe Biologics & Biosimilars Sales by Country
- 7.1.2 Europe Biologics & Biosimilars Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biologics & Biosimilars Market Facts & Figures by Type
- 7.3 Europe Biologics & Biosimilars Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Biologics & Biosimilars by Region
- 8.1.1 Asia Pacific Biologics & Biosimilars Sales by Region
- 8.1.2 Asia Pacific Biologics & Biosimilars Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Biologics & Biosimilars Market Facts & Figures by Type
- 8.3 Asia Pacific Biologics & Biosimilars Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Biologics & Biosimilars by Country
- 9.1.1 Latin America Biologics & Biosimilars Sales by Country
- 9.1.2 Latin America Biologics & Biosimilars Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Biologics & Biosimilars Market Facts & Figures by Type
- 9.3 Central & South America Biologics & Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Biologics & Biosimilars by Country
- 10.1.1 Middle East and Africa Biologics & Biosimilars Sales by Country
- 10.1.2 Middle East and Africa Biologics & Biosimilars Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Biologics & Biosimilars Market Facts & Figures by Type
- 10.3 Middle East and Africa Biologics & Biosimilars Market Facts & Figures by Application
11 Company Profiles
- 11.1 fizer
- 11.1.1 fizer Corporation Information
- 11.1.2 fizer Description and Business Overview
- 11.1.3 fizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 fizer Biologics & Biosimilars Products Offered
- 11.1.5 fizer Related Developments
- 11.2 Roche
- 11.2.1 Roche Corporation Information
- 11.2.2 Roche Description and Business Overview
- 11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Roche Biologics & Biosimilars Products Offered
- 11.2.5 Roche Related Developments
- 11.3 Amgen
- 11.3.1 Amgen Corporation Information
- 11.3.2 Amgen Description and Business Overview
- 11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Amgen Biologics & Biosimilars Products Offered
- 11.3.5 Amgen Related Developments
- 11.4 AbbVie
- 11.4.1 AbbVie Corporation Information
- 11.4.2 AbbVie Description and Business Overview
- 11.4.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 AbbVie Biologics & Biosimilars Products Offered
- 11.4.5 AbbVie Related Developments
- 11.5 Sanofi
- 11.5.1 Sanofi Corporation Information
- 11.5.2 Sanofi Description and Business Overview
- 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sanofi Biologics & Biosimilars Products Offered
- 11.5.5 Sanofi Related Developments
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Corporation Information
- 11.6.2 Johnson & Johnson Description and Business Overview
- 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Johnson & Johnson Biologics & Biosimilars Products Offered
- 11.6.5 Johnson & Johnson Related Developments
- 11.7 Novo Nordisk
- 11.7.1 Novo Nordisk Corporation Information
- 11.7.2 Novo Nordisk Description and Business Overview
- 11.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Novo Nordisk Biologics & Biosimilars Products Offered
- 11.7.5 Novo Nordisk Related Developments
- 11.8 Novartis
- 11.8.1 Novartis Corporation Information
- 11.8.2 Novartis Description and Business Overview
- 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Novartis Biologics & Biosimilars Products Offered
- 11.8.5 Novartis Related Developments
- 11.9 Merck
- 11.9.1 Merck Corporation Information
- 11.9.2 Merck Description and Business Overview
- 11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Merck Biologics & Biosimilars Products Offered
- 11.9.5 Merck Related Developments
- 11.10 Lilly
- 11.10.1 Lilly Corporation Information
- 11.10.2 Lilly Description and Business Overview
- 11.10.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Lilly Biologics & Biosimilars Products Offered
- 11.10.5 Lilly Related Developments
- 11.1 fizer
- 11.1.1 fizer Corporation Information
- 11.1.2 fizer Description and Business Overview
- 11.1.3 fizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 fizer Biologics & Biosimilars Products Offered
- 11.1.5 fizer Related Developments
- 11.12 Changchun High Tech
- 11.12.1 Changchun High Tech Corporation Information
- 11.12.2 Changchun High Tech Description and Business Overview
- 11.12.3 Changchun High Tech Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Changchun High Tech Products Offered
- 11.12.5 Changchun High Tech Related Developments
- 11.13 CP Guojian Pharmacy
- 11.13.1 CP Guojian Pharmacy Corporation Information
- 11.13.2 CP Guojian Pharmacy Description and Business Overview
- 11.13.3 CP Guojian Pharmacy Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 CP Guojian Pharmacy Products Offered
- 11.13.5 CP Guojian Pharmacy Related Developments
- 11.14 Biotech Pharma
- 11.14.1 Biotech Pharma Corporation Information
- 11.14.2 Biotech Pharma Description and Business Overview
- 11.14.3 Biotech Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Biotech Pharma Products Offered
- 11.14.5 Biotech Pharma Related Developments
- 11.15 Gelgen Biopharma
- 11.15.1 Gelgen Biopharma Corporation Information
- 11.15.2 Gelgen Biopharma Description and Business Overview
- 11.15.3 Gelgen Biopharma Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Gelgen Biopharma Products Offered
- 11.15.5 Gelgen Biopharma Related Developments
- 11.16 Sandoz
- 11.16.1 Sandoz Corporation Information
- 11.16.2 Sandoz Description and Business Overview
- 11.16.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Sandoz Products Offered
- 11.16.5 Sandoz Related Developments
- 11.17 Teva
- 11.17.1 Teva Corporation Information
- 11.17.2 Teva Description and Business Overview
- 11.17.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Teva Products Offered
- 11.17.5 Teva Related Developments
- 11.18 Hospira
- 11.18.1 Hospira Corporation Information
- 11.18.2 Hospira Description and Business Overview
- 11.18.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Hospira Products Offered
- 11.18.5 Hospira Related Developments
- 11.19 Mylan
- 11.19.1 Mylan Corporation Information
- 11.19.2 Mylan Description and Business Overview
- 11.19.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Mylan Products Offered
- 11.19.5 Mylan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Biologics & Biosimilars Market Estimates and Projections by Region
- 12.1.1 Global Biologics & Biosimilars Sales Forecast by Regions 2021-2026
- 12.1.2 Global Biologics & Biosimilars Revenue Forecast by Regions 2021-2026
- 12.2 North America Biologics & Biosimilars Market Size Forecast (2021-2026)
- 12.2.1 North America: Biologics & Biosimilars Sales Forecast (2021-2026)
- 12.2.2 North America: Biologics & Biosimilars Revenue Forecast (2021-2026)
- 12.2.3 North America: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
- 12.3 Europe Biologics & Biosimilars Market Size Forecast (2021-2026)
- 12.3.1 Europe: Biologics & Biosimilars Sales Forecast (2021-2026)
- 12.3.2 Europe: Biologics & Biosimilars Revenue Forecast (2021-2026)
- 12.3.3 Europe: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Biologics & Biosimilars Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Biologics & Biosimilars Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Biologics & Biosimilars Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Biologics & Biosimilars Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Biologics & Biosimilars Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Biologics & Biosimilars Sales Forecast (2021-2026)
- 12.5.2 Latin America: Biologics & Biosimilars Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Biologics & Biosimilars Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Biologics & Biosimilars Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Biologics & Biosimilars Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Biologics & Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biologics & Biosimilars Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biologics & Biosimilars . Industry analysis & Market Report on Biologics & Biosimilars is a syndicated market report, published as Global Biologics & Biosimilars Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Biologics & Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
